Despite multimodal therapy. prognosis of pediatric intracranial ependymomas remains poor with a 5-year survival rate below 70% and frequent late deaths. This multicentric European study evaluated putative prognostic biomarkers. Tenascin-C (TNC) immunohistochemical expression and copy number status of 1q25 were retained for a pooled analysis of 5 independent cohorts. https://www.chiggate.com/turbo-air-m3f72-3-n-78-wide-m3-series-reach-in-freezer-featuring-three-solid-doors-energy-star-online-now/